On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
The gut microbiome is a critical mediator in the interaction between an individual and their nutritional environment. As such, it has great potential as a target for the prevention and treatment of diet-related metabolic diseases.
This talk reports recent large-scale, multi-omic studies of the gut microbiome in type 2 diabetes and non-alcoholic fatty liver disease. In doing so, it addresses the role of microbially-mediated inflammation in the onset and development of both diseases. It also highlights the challenges inherent in microbiome studies, where causality may be attributed at the level of a single species, a clade, or a complex community.
